Alessia Castellino

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti et al. · The Lancet Oncology · 2014 · 182 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +9

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Annalisa Chiappella, Maurizio Martelli, Emanuele Angelucci et al. · The Lancet Oncology · 2017 · 129 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Radiation Oncology +10

Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018

Alessia Castellino, José S. Pulido, Patrick B. Johnston et al. · American Journal of Hematology · 2018 · 87 citations · Full text

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi

Annalisa Chiappella, Alessandra Tucci, Alessia Castellino et al. · Haematologica · 2013 · 59 citations · Full text

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Alessia Castellino, Annalisa Chiappella, Betsy LaPlant et al. · Blood Cancer Journal · 2018 · 38 citations · Full text